The Merger and Acquisition Deals of 2014 provides comprehensive understanding and unprecedented access to the M&A deals and agreements entered into by the worlds leading healthcare companies during 2014.
Using these reports, dealmakers will effectively and efficiently gain insight into the M&A activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide.
The initial chapters of this report provide an orientation of 2014’s M&A dealmaking and business activities.
Chapter 1 provides an overview of the trends in M&A dealmaking during 2014.
Chapter 2 provides a review of the leading M&A deals during 2014. Deals are listed by headline value, signed by big pharma and big biotech, and most active biopharma. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.
Chapter 3 provides a comprehensive listing of the top 50 big pharma companies with a brief summary followed by a comprehensive listing of 2014 M&A deals, as well as contract documents available in the public domain. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
Chapter 4 provides a comprehensive directory of all M&A deals announced during 2014.
The chapter is organized by company A-Z. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
The report series also includes numerous tables and figures that illustrate the trends and activities in bigpharma M&A dealmaking during 2014.
In conclusion, this report provides everything a prospective M&A dealmaker needs to know about partnering in the research, development and commercialization of technologies and products during 2014
Table Of Contents
Merger and Acquisition Deals and Alliances of 2014 Executive Summary
Chapter 1 - Trends in MandA dealmaking during 2014
1.1. Dealmaking activity by month 1.2. MandA by therapy area 1.3. MandA by industry sector
Chapter 2 - Leading MandA deals during 2014
2.1. Introduction 2.2. Top deals by value during 2014 2.3 Most active MandA dealmakers during 2014
Chapter 3 - Big pharma MandA deals during 2014
3.1. Introduction 3.2. How to use big pharma MandA deals 3.3. Big pharma MandA company profiles for 2014 Abbott Actavis Actelion Allergan Amgen Aspen Pharmacare Astellas AstraZeneca Baxter International Bayer Biogen Idec Boehringer Ingelheim Bristol-Myers Squibb Celgene CSL Daiichi Sankyo Dainippon Sumitomo Eisai Eli Lilly Endo Pharmaceuticals Forest Laboratories Galderma Gilead Sciences GlaxoSmithKline Grifols Hospira Johnson and Johnson Kyowa Hakko Kirin Lundbeck Menarini Merck and Co Merck KGaA Mitsubishi Tanabe Novartis Novo Nordisk Otsuka Pfizer Purdue Roche Sanofi Servier Shionogi Shire Takeda Teva Valeant Warner Chilcott Watson
Chapter 4 - MandA deals directory 2014
4.1. Introduction 4.2. Company A-Z
About Wildwood Ventures
Current Partnering Current Agreements Current Reports Recent titles from CurrentPartnering Order Form - Reports